[1]
İsmail Engin, A. E. Duman, H. E. Ataoğlu, A. Çifçibaşı Örmeci, and Şule Poturoğlu, “Predictors of eligibility for reimbursement of antiviral treatment in HBe-Ag negative chronic hepatitis B patients with high ALT levels: Predictors of eligibility for reimbursement of antiviral treatment”, J Surg Med, vol. 6, no. 7, pp. 705–708, Jul. 2022.